SCHEMBL7864100

SCHEMBL7864100

[CH2][C@@H](c1ccccc1)c1ccc(C)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.50
ACHE P22303 2/20 0.50
TSHR P16473 1/20 0.50
ALOX12 P18054 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.42
HPGD P15428 1/20 0.42
CHRNA7 P36544 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
CNR1 P21554 2/20 0.41
CNR2 P34972 2/20 0.41
OPRM1 P35372 2/20 0.40
OPRD1 P41143 2/20 0.40
OPRK1 P41145 2/20 0.40
OPRL1 P41146 2/20 0.40
CYP19A1 P11511 1/20 0.40
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
SLC6A3 Q01959 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4068746 1.00 LMNA (0.50) LMNAACHETSHRALOX12SMN1; SMN2
SCHEMBL3534179 0.92 ACHE (0.50) LMNAACHETSHRALOX12HPGD
SCHEMBL38016 0.83 DPP4 (0.50) LMNATSHRSLC6A3
SCHEMBL4668741 0.82 LMNA (0.48) LMNAACHETSHRALOX12SMN1; SMN2
SCHEMBL8327671 0.81 LMNA (0.42) LMNAACHETSHRALOX12SMN1; SMN2
SCHEMBL12199145 0.81 LMNA (0.53) LMNAACHETSHRALOX12SMN1; SMN2
SCHEMBL3657920 0.81 LMNA (0.53) LMNAACHETSHRALOX12SMN1; SMN2
SCHEMBL60997 0.81 LMNA (0.53) LMNAACHETSHRALOX12SMN1; SMN2
SCHEMBL17923689 0.81 LMNA (0.53) LMNAACHETSHRALOX12SMN1; SMN2
SCHEMBL28995862 0.80 DPP4 (0.47) LMNATSHRSLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1148047-A2 Processes for preparing cyclic compounds DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2001-10-24 EP disclosed